AI assistant
PRO MEDICUS LIMITED — AGM Information 2008
Nov 13, 2008
65579_rns_2008-11-13_6b2ad585-9bd0-4231-97e6-c07cc7cc9ad3.pdf
AGM Information
Open in viewerOpens in your device viewer

We offer a Partnership into the Future
Annual General MeetingNovember 14th2008



PROMEDICUS
•Mel Ward - Chairman

Board Members


- Mel Ward Chairman
- David Chambers CEO & Managing Director
- Sam Hupert Deputy Chairman & Executive Director
- Anthony Hall Executive Director
- Peter Jonson Non-Executive Director
- Peter Kempen Non-Executive Director

Officers


- Sandy McKendrick Company Secretary
- Danny Tauber Chief Operating Officer
- Clayton Hatch Finance Manager
- Stuart Painter Ernst and Young Auditor

Pro Medicus – In Perspective


- •2007/08 another successful year
- •8th year of sustained growth
- • Continued operation in Australia, and North America and the U.K.

Pro Medicus – 2007/08 Highlights


- •Record revenue of $15.34 million – up 17.8%
- •Net profit of $7.9 million – up 12.5%
- •Most profitable year in company's history
- •3.25c per share final dividend
- •Total dividend for year of 6.0 cents fully franked
- •Cash reserves increase 16% to $12.9 million
- •Company remains debt-free

2007/08 - The Year in Review


- • Australia Digital Imaging sales reach 'tipping point'
- • Continued growth of e:health platform which at 10% growth reaches 3.52 M transactions
- Well positioned in both local and overseas markets
- • New Agreement with Agfa-Gevaert in North America
- • Building platform for future growth through investment in human capital and R&D

Pro Medicus – Looking Forward


- • World-wide – all countries and companies face more volatile and uncertain conditions
- • Share market and exchange rate will present challenges
- • Maturing market and volatility in Australia validates decision to go offshore
- •Our strategy still sound

Pro Medicus - Strategy


| fBbdttesoreessems•y | +++ |
|---|---|
| Bittesspporserces•uv | +++ |
| fBltesaeormone•vuy | +++ |
| OAliihttsraanrgancgro•uw | |
| Ridlttteananeerageconracsv-- | ++ |
| Ntteconracsw-- | + |
| GNhtero•ww | |
| ffDlhkteeoposoremaresv-- | ++ |
| ()Allilddancesoannew-- | ++ |
| MdAiiitergersancqsonsu-- | ?++ |

Pro Medicus - Share Market


- • Financial crises heralds fears of recession and represents some unforeseen challenges
- • Debt free balance sheet with strong cash reserves provides capacity to weather storm
- • Healthcare still considered largely recession proof
- • Strong Australian core business and established position
- • Digital integration and North American position remain keys to future growth
- •PME remains healthy with positive outlook

Pro Medicus Dividend


- • Final dividend 3.25 cInterim dividend 2.75 c
- •No special dividend paid
- • Foreshadowed last year the benefit of finding a good M&A candidate particularly in North America
- • This opportunity represents the best use of your reserves

M&A - Activities


- • Have identified and studied a number of acquisition opportunities in North America and entered into discussions
- • Ailing economies and downward movement in exchange rates renders conditions adverse to goforward
- •Deferred action until conditions improve
- • Costs incurred on M&A activities have been expensed in the year
- • But cooperating actively with companies in the market

Pro Medicus – Looking Ahead


- • Competition will be tough, and economic seas may be rough with deferred capital spending
- • Well placed to weather a difficult economic climate
- •Strong Balance Sheet
- •Cash reserves at $12.89 M
- •Long-term client relationships
- •Balanced growth strategy
- •Healthcare typically recession proof

Pro Medicus – In Summary


- • Board and Management (re-shaped)
- •Thanks to Directors
- • Congratulations to Management and Staff
- •Creativity, enthusiasm, hard work


PROMEDICUS
• David Chambers CEO

A solid foundation underpins our company's well defined growth path


- •Our business has a solid basis in Australia
- • International footprint well established in U.S.A., Canada and U.K.
- • 25 years Industry knowledge and experience of Radiology Information Systems
- • Proven in some of the largest practices in the world
- • Focused not only on the practice of Radiology but also with expansion of e:health
- •In partnership with large International players

2007/08 Business Highlights


- •Record revenue of $15.34 million – up 17.8%
- •Net profit of $7.9 million – up 12.5%
- • Ongoing successful RIS placements in U.S., Canada and the U.K.
- • New Agreement with Agfa-Gevaert Limited in U.S.A.
- •Forging new strategic alliances

2007/08 Australian Highlights


- Revenue increased by 33.1% from $9.4M to $12.5M
- 'Tipping point' reached with 125 practices adopting PME digital technology up from 40 last year
- New projects with other PACS vendors yields results
- Success in Hospital market e.g. St.VincentsPrivate, Mater in Sydney, Cabrini in Melbourne
- 10% growth in number of doctors as registered users of promedicus.net (to 28,000)

2007/08 North America Highlights


- • North American revenues impacted by:
- •Currency impact
- •Agfa 'tail off' effect
- •New agreement signed with Agfa Gevaert
- • Establishment of PME presence in North America
- •First 'direct' project successfully completed
- • Agfa continue to quote our products and offer up opportunities
- •Other PACS companies offer up collaboration

New North American Business Model


- • Allows PME to focus on out-patient imaging centre market
- • Satisfies clients requests for more direct contact with PME
- •Opens door for other products like e:health
- •Leverages PME's rapid implementation model
- • Addresses other markets segments e.g. orthopedics and cardiology
- • Allows collaboration with other PACS vendors –broadens addressable market

What are the benefits?


- • Continue to work with Agfa and be their preferred RIS for Imaging Centers
- • Bring PME knowledge and track record into a direct client relationship placing us in drivers seat
- • Company will now get full mark-ups, but costs of establishment
- • Retain access to some of Agfa's most highly skilled and knowledgeable staff
- • Growth will slow but momentum to build over next 12-18 months with some investment

USA & Canada Resources & Client Sites

US SitesCanada SitesPME resources

How to Build Business* - U.S.A.


More than half (53 percent) of survey respondents see adding or providing remote access to clinical images and information as the No. 1 reason to gain physician mindshare and referrals.
That goes hand in hand with just about half (49 percent) who rank improving report/image turn-around time as the next most important way to earn referrals.
| TOP 10 CLINICAL IT System Purchases | |||
|---|---|---|---|
| 1 Radiology information system | 6 HIS | ||
| 2 Cardiology PACS | ED information sys | ||
| Badiology PACS | 8 Nuclear medicine P |


Imaging Center market - highest growth



Source: Frost & Sullivan

Mantra: "It's about speed, scalability, stability and yoursuccess: all informed by the key attribute of support"


- • Our deep understanding of the practice of radiology is placed at the disposal of our clients to deliver better clinical and business outcomes
- • Our clients enlist a team that not only knows the solution but also understands their business.
- •With unrivalled responsiveness and support
- • Experience built from a diverse range of more than 400 practices world-wide:
- •Imaging Centres
- •Hospitals
- •Specialist Centres

Specialist experience with large groups


• Virginia Based integrated healthcare group with 40 outpatient imaging centres
Canada
• Calgary based diagnostic imaging group with 28 imaging centre sites
Australia
• Australia's largest private radiology group with 170 diagnostic imaging centre sites
United Kingdom
• Private Health Care Group with 30 imaging centre sites across England

Building a platform for future growth


- • Establishment of Pro Medicus own presence in North America.
- •Business now registered in Delaware
- •Offices established in New Jersey
- • Investment in new people and infrastructure
- •Sales
- •Implementation
- •Support
- • Pursuing major development program aimed at delivering new technology platform

Transfer our knowledge to new related products and markets


New products, new markets
Products


Markets

Development Update


- • Delivered new capabilities into US product
- •integration of 3rd party billing modules
- • integration of leading US electronic medical record (EMR) product.
- • R&D effort
- •Ongoing build up of core competencies.
- • underpins future by transitioning products to new technology platform.
- • cornerstone for future growth in local and overseas markets.


- • Healthcare a defensive position - Governments continuing to reduce Healthcare costs through technology
- • Costs in US Dollars will be offset by future earnings also in US currency
- • Up-front costs offset by assistance in logistics and channel support from Agfa
- • Infrastructure costs low in start up phase and well under control through sensible containment measures
- •Strong balance sheet with cash in bank
- •Well positioned for M&A when markets stabilise

Pro Medicus Outlook


- •Have been travelling well
- •We are in a transition period
- • Further potential remains in Australia but market is maturing
- •U.S. is still the key to future growth
- •RSNA in December is our primary launch pad
- • Have opportunity hopper, but must close sales and build momentum
- • FY 2008/09 – a year of re-investment to build and bridge a platform of success for the future


We offer a Partnership into the Future

Radiology Information Solutions
CEO Incentive Scheme

- •2008 /09 a year of transition
- •Emphasis placed on scaling company for growth
- •Performance parameters aligned with shareholders interests
- • Building company for minimum 3 x growth
- •EPS
- •Share price accretion
- •Renewable agreement
